Two T1D Patients Achieve Insulin Independence After Stem Cell Transplants
(MedPage Today) -- SAN DIEGO -- Stem cell-derived islet cell therapy continued to show promise for the management of type 1 diabetes (T1D) with severe hypoglycemia, according to results from a small phase I/II clinical trial.
All six Part A... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2023 Category: Primary Care Source Type: news
MRI shows how social isolation can lead to cognitive decline
MRI shows that social isolation can lead to cognitive decline, a study fro...Read more on AuntMinnie.comRelated Reading:
High blood pressure linked to higher risk of cognitive decline
ISMRM: Ultrafast MRI protocol cuts dementia diagnosis time by more than 60%
ISMRM: Chemotherapy for breast cancer impacts women's cognitive health
MRI shows that brains of persons with type 1 diabetes age faster
CMS to cover Alzheimer's drugs for patients enrolled in registry (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2023 Category: Radiology Source Type: news
Athletes With Type 1 Diabetes Ignore Hypoglycemia Warnings Athletes With Type 1 Diabetes Ignore Hypoglycemia Warnings
Survey results from 102 US adults with type 1 diabetes who exercise often showed concerning high rates of behaviors that run counter to expert recommendations and put patients at risk of hypoglycemia.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 23, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Is Education or Screening Better for Type 1 Diabetes? Is Education or Screening Better for Type 1 Diabetes?
Some experts argue that voluntary screening for type 1 diabetes should be included in standard care, but others doubt that this practice would prove beneficial.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - June 19, 2023 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news
Why Exercise Is Often a Challenge for Folks With Type 1 Diabetes
FRIDAY, June 16, 2023 -- It can be challenging for people with type 1 diabetes to exercise safely while controlling their blood sugar.
People with the condition often struggle with this balance, according to a new study based on a survey conducted... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 16, 2023 Category: General Medicine Source Type: news
Machine-learning method used for self-driving cars could improve lives of type-1 diabetes patients
The same type of machine learning methods used to pilot self-driving cars and beat top chess players could help type-1 diabetes sufferers keep their blood glucose levels in a safe range. (Source: University of Bristol news)
Source: University of Bristol news - June 14, 2023 Category: Universities & Medical Training Tags: Research; Faculty of Engineering, Faculty of Engineering, School of Computer Science, Electrical and Electronic Engineering, and Engineering Maths; Press Release Source Type: news
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
AstraZeneca has entered into an exciting collaboration, exclusive option and license agreement with Quell Therapeutics to develop multiple engineered T-regulator (Treg) cell therapies that have the potential to be curative in Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD) indications.
Under the terms of the agreement, Quell's proprietary toolbox of Treg cell engineering modules, including its innovative Foxp3 Phenotype Lock will be leveraged to develop autologous multi-modular Treg cell therapy candidates for major autoimmune disease indications. (Source: World Pharma News)
Source: World Pharma News - June 12, 2023 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
AstraZeneca enlists UK Treg biotech for type 1 diabetes, inflammatory bowel disease deal featuring $85M upfront
AstraZeneca is partnering with Quell Therapeutics to develop regulatory T cell therapies for type 1 diabetes and inflammatory bowel disease, joining the growing movement of companies and academic groups developing cell therapies for autoimmune diseases.…#quell #1diabetes #academic #royalties (Source: Reuters: Health)
Source: Reuters: Health - June 9, 2023 Category: Consumer Health News Source Type: news
Less than half of diabetes patients had all recommended checks last year
Fewer than half of diabetes patients had all recommended checks last year, an audit has found. More needs to be done to address the backlog of routine diabetes care and avoid preventable deaths from the condition, the Diabetes UK report warned. Too many patients with both type 1 and type 2 diabetes were missing on... Read moreThe post Less than half of diabetes patients had all recommended checks last year appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - June 7, 2023 Category: Nursing Authors: Megan Ford Tags: Clinical Diabetes Latest news Source Type: news
New Nonhormonal Hot Flash Recs; Global Plastics Treaty; SGLT2 & Lower Cancer Risk?
(MedPage Today) -- The North American Menopause Society released an updated position statement on the latest nonhormonal hot flash treatment options. (Menopause)
A longitudinal analysis showed that while kids with type 1 diabetes rapidly progressed... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 6, 2023 Category: Endocrinology Source Type: news
As it advances its Type 1 Diabetes treatment, vTv Therapeutics increases cash position, decreases net loss in Q1
With a significant jump in cash, High Point ’s public biopharmaceutical company vTv Therapeutics lessened its net loss in the first quarter of 2023 to $4.5 million. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 6, 2023 Category: Pharmaceuticals Authors: Lillian Johnson Source Type: news
ISMRM: Chemotherapy for breast cancer impacts women's cognitive health
TORONTO - MRI shows that chemotherapy for breast cancer negatively affects women'...Read more on AuntMinnie.comRelated Reading:
MRI shows that brains of persons with type 1 diabetes age faster
Can brain MRI exams of fighter jet pilots reveal space travel effects?
Diffusion kurtosis imaging helps identify cognitive impairment
Brain PET/MRI scans reveal visual snow syndrome
MRI reveals link between obesity, poor pediatric brain health (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 6, 2023 Category: Radiology Source Type: news
MRI shows that brains of persons with type 1 diabetes age faster
MR imaging shows that the brains of individuals with type 1 diabetes age faste...Read more on AuntMinnie.comRelated Reading:
MRI markers show racial disparities in brain health
MRI detects signs of early aging in people with poor heart health
AI model predicts Alzheimer's disease brain changes on MRI
MRI links air pollution to dementia risk in women
MRI shows intracranial volume changes through adulthood (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 1, 2023 Category: Radiology Source Type: news
Study Suggests Increase in Brain Aging in Those With Type 1 Diabetes
(MedPage Today) -- Patients with type 1 diabetes (T1D) may have advanced brain aging compared with those without T1D, though this didn't come with early signs of Alzheimer's disease-related neurodegeneration, according to a cohort study.
Participants... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - June 1, 2023 Category: Psychiatry Source Type: news
FDA Clears New Insulin Pump and Algorithm-Based Software
THURSDAY, May 25, 2023 -- The U.S. Food and Drug Administration (FDA) cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software (Beta Bionics) for use in people at least 6 years of age with type 1 diabetes.
These two devices, in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 25, 2023 Category: Pharmaceuticals Source Type: news
